Can you take two cialis

pmid:26495912, doi:10.1515/pjs-2015-0075, randomized controlled trial, santosh kumar, rajesh roat, shrawan kumar, adult, double-blind method, drug therapy, combination, erectile dysfunction / drug therapy*, erectile dysfunction / prevention & control, humans, male, middle aged, pentoxifylline / administration & dosage*, prospective studies, severity of illness index, tadalafil / administration & dosage*, treatment outcome, vasodilator agents / administration & dosage*, pubmed abstract, nih, nlm, ncbi, national institutes of health, national center for biotechnology information, national library of medicine, medline

Combination Therapy Of Tadalafil And Pentoxifylline In Severe Erectile Dysfunction; A Prospective Randomized Trial.
The aim of the study was to assess efficacy of Tadalafil alone versus Tadalafil plus Pentoxifylline in the treatment of erectile dysfunction by using self administered IIEF-5 questionnaire.
Material and methods: Two hundred and thirty seven patients presenting with ED at andrology OPD were evaluated for ED by a self administered IIEF (International Index of Erectile Function) questionnaire. Patients were systematically randomized by computer generated random table into two groups groups namely, group A: Tadalafil only group, group B: combination of Tadalafil + Pentoxifyl-line. All the patients were re-assessed by IIEF-5 questionnaire after 8 weeks of medical therapy. Statistical analysis was performed using student’s unpaired t-test, paired t-test, chi square test. p-value.
Results: Two hundred and thirty seven patients were included in the present study, in group A: 92 patients (78.6%) showed improvement in their IIEF score after 8 weeks of tadalafil treatment. While in group B, overall 104 patients(86.6%) showed improvement after combination of Tadalafil and Pentoxifylline. There was a statistically significant difference of percentage change in IIEF score was seen in group B (group A 90.7±15.2%, group B 95.6±13.4%; p value – 0.014). We found this difference even more statistically significant in patients with severe ED (group A 72.7±47.2%, group B 132.3±54.3%; p value – 0.000). There was no significant difference in between the two groups with regards to occur-rence of side effects.
Conclusions: Both tadalafil and combination of Tadalafil + Pentoxifylline improve erectile function in patients of ED. Patients with severe ED showed much significant improvement in erectile function with combination therapy.
Similar articles.
Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V. Skoumal R, et al. Eur Urol. 2004 Sep;46(3):362-9; discussion 369. doi: 10.1016/j.eururo.2004.04.026. Eur Urol. 2004. PMID: 15306109 Clinical Trial.
Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S. Hamidi Madani A, et al. J Sex Med. 2013 Apr;10(4):1146-50. doi: 10.1111/jsm.12047. Epub 2013 Jan 24. J Sex Med. 2013. PMID: 23347176 Clinical Trial.
Carrier S, Brock GB, Pommerville PJ, Shin J, Anglin G, Whitaker S, Beasley CM Jr. Carrier S, et al. J Sex Med. 2005 Sep;2(5):685-98. doi: 10.1111/j.1743-6109.2005.00097.x. J Sex Med. 2005. PMID: 16422827 Clinical Trial.
Porst H, Gacci M, Büttner H, Henneges C, Boess F. Porst H, et al. Eur Urol. 2014 Feb;65(2):455-64. doi: 10.1016/j.eururo.2013.09.037. Epub 2013 Oct 2. Eur Urol. 2014. PMID: 24119319.
Zhang Y, Zhang W, Dai Y, Jiang H, Zhang X. Zhang Y, et al. Sex Med. 2021 Jun;9(3):100356. doi: 10.1016/j.esxm.2021.100356. Epub 2021 May 26. Sex Med. 2021. PMID: 34051538 Free PMC article. Review.
Cited by.
Pierre CJ, Azeez TA, Rossetti ML, Gordon BS, La Favor JD. Pierre CJ, et al. Life Sci. 2022 Dec 1;310:121082. doi: 10.1016/j.lfs.2022.121082. Epub 2022 Oct 15. Life Sci. 2022. PMID: 36252696.
Hatampour M, Sohrabi K, Mazdak H, Ghadimi K, Salehi H, Kazemi R. Hatampour M, et al. Am J Clin Exp Urol. 2022 Feb 15;10(1):25-30. eCollection 2022. Am J Clin Exp Urol. 2022. PMID: 35291415 Free PMC article.
El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Elkaeed EB, Al-Karmalawy AA, Bahaa MM. El-Haggar SM, et al. J Inflamm Res. 2022 Feb 19;15:1159-1172. doi: 10.2147/JIR.S346608. eCollection 2022. J Inflamm Res. 2022. PMID: 35221706 Free PMC article. Retracted.
Lu Y, Su H, Zhang J, Wang Y, Li H. Lu Y, et al. Front Pharmacol. 2022 Jan 12;12:789787. doi: 10.3389/fphar.2021.789787. eCollection 2021. Front Pharmacol. 2022. PMID: 35095501 Free PMC article. Review.
Mykoniatis I, Pyrgidis N, Sokolakis I, Ouranidis A, Sountoulides P, Haidich AB, van Renterghem K, Hatzichristodoulou G, Hatzichristou D. Mykoniatis I, et al. JAMA Netw Open. 2021 Feb 1;4(2):e2036337. doi: 10.1001/jamanetworkopen.2020.36337. JAMA Netw Open. 2021. PMID: 33599772 Free PMC article.